Delivering next generation pharmaceuticals
Recieve CPI's latest news delivered to your inbox.Sign up to our newsletter
Pharmaceutical manufacturing is changing. The traditional model of large scale batch manufacturing facilities with high capital costs cannot support the current industry shift towards personalised medicines, which requires a flexible production line capable of quickly switching between small lots of a wide range of drugs. CPI is helping companies develop and test the latest in innovative pharmaceutical manufacturing technologies.
In an industry where an estimated £11.2m is spent on research in the UK every day, the ability to translate cutting edge research into a marketable product is critical. CPI can help academia and companies of all sizes to develop the next generation of pharmaceutical products and processes at speed and with less risk.
Utilising our state of the art open access facilities and the multi-disciplinary biologics and formulations expertise of our staff, CPI can help you successfully guide your products and processes from concept to commercialisation.
The CPI National Biologics Manufacturing Centre opened in 2015 to help our partners develop innovative biopharmaceutical products and explore manufacturing technologies for personalised pharmaceuticals by scaling down traditional biopharmaceutical manufacturing.
Our printable electronics capabilities support the development of smart pharmaceutical packaging solutions, enabling a new generation of interactive packaging which monitors dosage, shelf life, tampering and counterfeiting and improves quality and convenience through simple displays or audible warnings and information.
In 2017 CPI will open it’s Biologics Factory of the Future facility. The centre, will provide organisations with the opportunity to develop and test precision medicine production technologies in a low risk, open access environment.